Gout/Crystal

RT @philipcrobinson: Patients aren’t getting to urate target in gout when treated with allopurinol. Are we using enough? #166 #ACR17 @Rheu…

20 Aug 2019

Social

87 #Gout patients treated with ULT and followed with serial Xrays and DECT scanning shows that lowering uric acid in a T2T strategy did not change xray over 2 years, but did show significantly less urate erosions by DECT. https://t.co/XRwkyyI4lr

Estimates suggest 8.3 million Gout pts in US; Another recent market estimates claims that worldwide 2016, there were 34.0 million prevalent cases of gout and forecasts and increase to 37.9 million by 2025. https://t.co/U868kzdvug

FDA reviews potential new gout drug Lesinurad (URAT-1 inhibitor) on friday. ULT for for use with allopurinol. https://t.co/tIXlgjQAOr

16 Sep 2016

Social

Long-term colchicine may be associated with lower rates of MI, but higher rates of GI adverse events. https://t.co/KtuOonOMci

31 Mar 2017

Social

Large US claims national database, current allopurinol use was assoc w/ 37% fewer CV events in gout & diabetes pts https://t.co/uE7KDxRnGC

29 May 2019

Social

Risk factors for gouty tophi that ulcerate include: glucocorticoid overuse, tophi duration, and the number of tophi. Based on a chinese study of 105 tophaceous patients of whom 33 developed ulcerations https://t.co/rzYTFCb5jk

Login, Register

A valid e-mail address. All e-mails from the system will be sent to this address. The e-mail address is not made public and will only be used if you wish to receive a new password or wish to receive certain news or notifications by e-mail.

Password *

Confirm password *

User picture

Files must be less than 256 MB.Allowed file types: png gif jpg jpeg.

Full name *

Reader Type *

Country *

Zip Code

Once registered, you can save articles via My Folder and will receive a daily digest of RheumNow headlines, original articles, blogs and useful downloads. You can manage your email preferences at any time through your profile

About

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for Rheumatologists and individuals working in related fields.
Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter. Learn More